» Articles » PMID: 14725161

Lifestyle Changes to Prevent BPH: Heart Healthy = Prostate Healthy

Overview
Journal Urol Nurs
Specialties Nursing
Urology
Date 2004 Jan 17
PMID 14725161
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Benign prostatic hyperplasia (BPH) is one of the most prevalent conditions found in men, and increases with age. Drug, surgical, and phytotherapy tend to dominate the medical literature when discussing potential treatments for this condition. These treatments have demonstrated remarkable effectiveness for the various degrees of BPH. However, the potential for lifestyle changes to actually prevent this disease or reduce the severity of this condition when used as an adjunct to conventional treatment is not only intriguing but is strongly supported by past limited studies. More research is needed, but the time is ripe to discuss with patients the potential lifestyle changes that could influence risk. Obesity, a lack of physical activity, dyslipidemia, diabetes, hypertension, a heart unhealthy diet, and other factors may significantly increase the risk of BPH. Patients should be told that factors that increase the risk of cardiovascular disease seem to be associated with an increased risk of BPH or a greater severity of BPH.

Citing Articles

Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.

Moyad M Curr Urol Rep. 2018; 19(12):104.

PMID: 30368693 DOI: 10.1007/s11934-018-0846-4.


Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention.

Moyad M, Vogelzang N Asian J Androl. 2015; 17(5):783-91.

PMID: 25657084 PMC: 4577591. DOI: 10.4103/1008-682X.148070.


Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group".

Weibl P, Klatte T, Laurinc P, Tomaskin R, Shariat S, Helbich M Wien Klin Wochenschr. 2014; 127(9-10):363-8.

PMID: 25447967 DOI: 10.1007/s00508-014-0668-4.